Lawrence-based Company Offers New Hope For Older, Lazy Eye Sufferers

Sept. 10, 2010 - PRLog -- There has been a long standing belief among doctors that if amblyopia, or lazy eye, is not caught by around age eight or nine, it might be too late to improve it.  Untreated, the condition has been known to cause permanent vision loss in the affected eye.  It is estimated 2 to 3% of the world’s population suffers from amblyopia.  RevitalVision, a Lawrence-based start-up company is now offering new hope with the only FDA-approved technology for treating amblyopia.

RevitalVision has the only FDA-approved program for improving amblyopia for patients nine and older. RevitalVision, recently released in the U.S., is a non-invasive program that a patient takes on their home computer utilizing technology developed by Nobel Prize Winner Dennis Gabor. The program improves vision by enhancing brain plasticity without surgery or drugs. This program is being prescribed and sold through the oversight of eye care professionals in Kansas City, in the U.S. and in various parts of the world.  RevitalVision is taken at home for 40, forty minute sessions.  Clinical study results report an improvement of more than 2 lines in vision improvement as measured on a standard eye examination chart.

“As a Professor, Eye Care Practitioner, and amblyopia patient, I was excited to discover the RevitalVision product and try it for myself.  I am thrilled with my results.  I am now recommending it to my teenage and adult amblyopia patients who quality for the program to improve their quality of vision,” stated Dr. Peter Shaw-McMinn, OD, senior partner of Sun City Vision Center, Sun City, Calif., and Assistant Professor at the Southern California School of Optometry.

# # #

RevitalVision is the world’s only clinically and scientifically proven*, non-surgical therapy to improve vision. It increases the communication between your eyes and your brain to help you see better without surgery, drugs or glasses.